endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

US de­clares mon­key­pox a na­tion­al health emer­gency, as new drug­mak­ers con­sid­er en­ter­ing vac­cine race

3 years ago
R&D
Pharma

Bio­haven touts surge in Nurtec sales ahead of Pfiz­er takeover

3 years ago
Pharma

AARP push­es for Medicare ne­go­ti­a­tions in TV ad as Con­gress tees up drug pric­ing leg­is­la­tion vote

3 years ago
Pharma
Marketing

Phar­ma brands chill in the phar­ma­cy re­tail aisle with new style ads on re­frig­er­a­tion screens

3 years ago
Pharma
Marketing

De­moc­rats se­cure sup­port from key sen­a­tor ahead of po­ten­tial drug pric­ing vote

3 years ago
Pharma
FDA+

Break­ing: Pfiz­er in hot pur­suit of a $5B buy­out of Glob­al Blood Ther­a­peu­tics — re­port

3 years ago
Deals

Gen­mab and BioN­Tech to col­lab­o­rate on new can­cer can­di­date; Small Aus­tralian biotech sees hope in brain metas­tases ...

3 years ago
News Briefing

Two years af­ter step­ping down amidst house ar­rest, Frank Zhang is back as Leg­end chair

3 years ago
People

Al San­drock prunes his post-Bio­gen voy­age with sim­i­lar fo­cus on ALS

3 years ago
R&D
Cell/Gene Tx

While Prax­is moves for­ward, Neu­ro­crine drops its es­sen­tial tremor drug

3 years ago
R&D

Aca­dia hits an­oth­er Nu­plazid road­block as the FDA doles out CRL and rec­om­mends an­oth­er tri­al

3 years ago
Pharma
FDA+

Ake­bi­a's ane­mia drug flunked Covid study — but count the bruised biotech 'ex­treme­ly en­cour­aged'

3 years ago
R&D
Coronavirus

Am­gen diss­es drug pric­ing bill, while amp­ing $4B rare drug com­pa­ny deal and up­com­ing Hu­mi­ra biosim launch

3 years ago
Pharma
Marketing

Am­gen sweeps last BC­MA BiTE stand­ing out of pipeline

3 years ago
R&D

Astel­las taps sea­soned CMO amid shift to on­col­o­gy; Doug Man­ion steps in­to a new Are­na fol­low­ing $6.7B buy­out

3 years ago
Peer Review

Pros­e­cu­tors fail to ex­tend ex-GSK sci­en­tist­s' sen­tences in trade se­crets case

3 years ago
Pharma
Law

No­vo Nordisk to make all dos­es of its weight loss drug avail­able in the US by end of the year

3 years ago
R&D

Bay­er CEO Wern­er Bau­mann says com­pa­ny is 'putting ma­jor lit­i­ga­tion be­hind us' while high­light­ing Q2 growth

3 years ago
Pharma

Bris­tol My­er­s' on­line ini­tia­tive ad­vo­cates work sup­port for MS pa­tients and care­givers

3 years ago
Pharma
Marketing

Sanofi fronts €300M to part­ner up with In­novent on Chi­na mar­ket, eye­ing quick piv­ot to com­mer­cial­iza­tion

3 years ago
Deals

Eli Lil­ly CEO Ricks echoes a grow­ing re­frain on price ne­go­ti­a­tions: 'We’ll fo­cus our re­sources on oth­er ar­eas'

3 years ago
Pharma

Man­u­fac­tur­ing roundup: So­ci­etal CD­MO nets new cus­tomers; Chime Bi­o­log­ics gets the OK to man­u­fac­ture an­ti­bod­ies

3 years ago
Manufacturing

FDA is­sues new guid­ance for changes to dis­pos­able man­u­fac­tur­ing ma­te­ri­als

3 years ago
FDA+
Manufacturing

Ther­mo Fish­er com­pletes $76M cell cul­ture man­u­fac­tur­ing site near Buf­fa­lo, NY

3 years ago
Manufacturing
First page Previous page 480481482483484485486 Next page Last page
A service from the Financial Times